PMcardio receives FDA Breakthrough Device Designation — read the full story
Get access

Powerful Medical Webinars & Events

Past Webinars & Events

Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024

Past
Award
November 18, 2024
8:00 -
12:00

Powerful Medical has been named the Best Science Pitch and Overall Winner at the prestigious American Heart Association (AHA) Health Tech Competition during the AHA 2024 Scientific Sessions held in Chicago, Illinois. This recognition underscores Powerful Medical’s leadership in innovative cardiovascular healthcare technology, with its flagship product, PMcardio, earning acclaim as a groundbreaking solution for diagnostics and care coordination.

Learn more

AHA2024 Scientific Sessions: External Independent Validations of PMcardio

Past
Talk
November 18, 2024
11:00 -
11:45

Join us at American Heart Association Scientific Sessions AHA2024 for a deep dive into the External Independent Validations of PMcardio, also known as the Queen of Hearts, during the “AI in ACS Session”! Explore how AI is transforming acute cardiac care through real-world studies.

Learn more

AI-Powered Smartphone Application for Detection of Left Ventricular Systolic Dysfunction using 12-Lead ECG

Past
Talk
November 18, 2024
11:00 -
11:15

At hashtag#AHA2024, Anthony Demolder, MD will spotlight how PMcardio is advancing heart failure diagnostics by detecting LVEF on the ECG for patients in primary care settings.

Learn more

Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System

Past
Talk
November 18, 2024
11:00 -
11:30

We’re proud to announce that Robert Herman, MD will present at AHA2024, unveiling new insights on AI in acute cardiac care! His presentation, “Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System,” highlights the role of PMcardio and AI-driven diagnostics in rapid cath lab activation for the chest pain patient pathway.

Learn more

Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion

Past
Talk
November 16, 2024
11:40 -
12:15

Join us at AHA2024 to hear Dr. Timea Kisova discuss a critical topic impacting cardiac care for women. In her talk, “Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion” Dr. Kisova will address disparities in timely intervention for female OMI patients, emphasizing the importance of prompt reperfusion.

Learn more

AHA Congress 2024 – Chicago

Past
Event
November 16, 2024
8:00 -
12:00

We are set to make a significant impact with multiple sessions highlighting our cutting-edge innovations in AI-driven cardiovascular care. Our team, alongside experts from Mount Sinai and Washington University Hospital in St. Louis, will present research demonstrating how our technology enhances diagnostic accuracy, enables early diagnosis, and expedites treatment – offering a glimpse into the future of cardiovascular medicine.

Learn More

Missed out? Subscribe for new webinar dates.

Your submission was successful

Don't miss these

More articles
Image is showing logos of the two companies mentioned in the text - PMcardio and Alphaiota
  • AI, News

Alphaiota Expands Strategic Partnership with PMcardio to Launch First AI-Powered Heart Attack Diagnostic Platform in Saudi Arabia

Alphaiota and PMcardio announce the expansion of their strategic partnership to bring the first AI-powered heart attack diagnostic solution to the Kingdom of Saudi Arabia. Developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics, PMcardio will be introduced by Alphaiota as the exclusive distributor in the region, marking a first-of-its-kind deployment in the Middle East.
Image ilustrating the VAIA grant reception containing logos of important public institutions
  • AI, News, STEMI/OMI

Powerful Medical Awarded €1M EU-Funded Grant by Slovak Ministry of Economy to Advance AI-ECG Heart Attack Diagnostics

Powerful Medical has received over €985,000 in funding from the Slovak Ministry of Economy, as part of the EU-funded Recovery and Resilience Plan. The grant supports the continued development of our AI-based ECG interpretation technology, focused on improving early diagnosis and treatment of acute coronary syndromes (ACS).
More articles

Ready to get started?

Get access

Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.

Logo of Next Gen EU
Logo of Next Gen EU

Products

Company

Resources

Legal

Envelope Linkedin-in Instagram Facebook-f

© Powerful Medical 2025

Privacy

&

Cookies

Legal

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.

Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Get access